Global Vascular Imaging Market Size Study & Forecast, by Modality (CT, MRI, Ultrasound, Nuclear Medicine) and End-Use (Hospitals, Imaging Centers) and Regional Forecasts 2025-2035

Description

The Global Vascular Imaging Market is valued at approximately USD 6.7 billion in 2024 and is projected to expand at a CAGR of 4.19% over the forecast period from 2025 to 2035. Vascular imaging encompasses a range of sophisticated diagnostic techniques that allow healthcare professionals to visualize and evaluate blood vessels throughout the body. These imaging modalities, including CT, MRI, Ultrasound, and Nuclear Medicine, play a pivotal role in diagnosing vascular disorders, guiding interventional procedures, and monitoring post-treatment outcomes. The increasing prevalence of cardiovascular diseases, combined with the rising adoption of advanced imaging systems, is driving market expansion. Furthermore, ongoing technological innovations, including high-resolution imaging, 3D reconstruction, and contrast-enhanced techniques, are enhancing the accuracy and efficiency of vascular imaging solutions worldwide.

Rising incidences of cardiovascular and peripheral vascular diseases are catalyzing the demand for non-invasive and minimally invasive diagnostic solutions. According to the World Health Organization, cardiovascular diseases account for nearly 17.9 million deaths annually, highlighting the urgency for early detection and effective management. Hospitals and imaging centers are increasingly investing in vascular imaging systems to ensure precise diagnosis, reduce procedural risks, and improve patient outcomes. Additionally, the integration of AI-driven imaging software, improved workflow efficiency, and enhanced image processing capabilities provide lucrative avenues for market growth. However, the adoption rate may be constrained by the high costs associated with advanced imaging modalities and a gradual shift toward preventive healthcare and telemedicine solutions.

Regionally, North America holds a dominant position in the vascular imaging market owing to its well-established healthcare infrastructure, high per capita healthcare expenditure, and extensive adoption of advanced imaging technologies. The U.S., in particular, leads due to robust reimbursement frameworks, growing cardiovascular disease awareness, and the presence of key market players. Europe follows closely, driven by increasing geriatric population, government initiatives promoting early disease detection, and technological advancements in imaging systems. The Asia Pacific region is anticipated to register the fastest growth during the forecast period, fueled by rising healthcare spending, expanding hospital networks, and increasing prevalence of lifestyle-related vascular disorders in countries such as China and India. Latin America and the Middle East & Africa are gradually witnessing growth due to increasing awareness, improving healthcare access, and supportive governmental policies.

Major market players included in this report are:

GE Healthcare
Siemens Healthineers
Philips Healthcare
Canon Medical Systems Corporation
Fujifilm Holdings Corporation
Hitachi Medical Corporation
Medtronic Plc
Baxter International Inc.
Boston Scientific Corporation
Bracco Imaging S.p.A
Canon U.S.A., Inc.
Shimadzu Corporation
Terumo Corporation
Koninklijke Philips N.V.
Stryker Corporation

Global Vascular Imaging Market Report Scope:

Historical Data - 2023, 2024
Base Year for Estimation - 2024
Forecast period - 2025-2035
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained below:

By Modality:

CT
MRI
Ultrasound
Nuclear Medicine

By End-Use:

Hospitals
Imaging Centers

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
South Africa
Rest of Middle East & Africa

Key Takeaways:

Market Estimates & Forecast for 10 years from 2025 to 2035.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

Chapter 1. Global Vascular Imaging Market Report Scope & Methodology

1.1. Research Objective
1.2. Research Methodology
- 1.2.1. Forecast Model
- 1.2.2. Desk Research
- 1.2.3. Top Down and Bottom-Up Approach
1.3. Research Attributes
1.4. Scope of the Study
- 1.4.1. Market Definition
- 1.4.2. Market Segmentation
1.5. Research Assumption
- 1.5.1. Inclusion & Exclusion
- 1.5.2. Limitations
- 1.5.3. Years Considered for the Study

Chapter 2. Executive Summary

2.1. CEO/CXO Standpoint
2.2. Strategic Insights
2.3. ESG Analysis
2.4. Key Findings

Chapter 3. Global Vascular Imaging Market Forces Analysis

3.1. Market Forces Shaping The Global Vascular Imaging Market (2024-2035)
3.2. Drivers
- 3.2.1. Rising prevalence of cardiovascular and peripheral vascular diseases
- 3.2.2. Increasing adoption of advanced imaging technologies (high-resolution CT/MRI, contrast-enhanced ultrasound)
3.3. Restraints
- 3.3.1. High capital expenditure and per-scan costs of advanced imaging systems
- 3.3.2. Limited reimbursement policies and regulatory complexity in certain regions
3.4. Opportunities
- 3.4.1. Integration of AI and advanced image-analysis software for improved diagnostics
- 3.4.2. Expansion of imaging infrastructure in emerging markets and outpatient imaging centers

Chapter 4. Global Vascular Imaging Industry Analysis

4.1. Porter's 5 Forces Model
- 4.1.1. Bargaining Power of Buyer
- 4.1.2. Bargaining Power of Supplier
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Forecast Model (2024-2035)
4.3. PESTEL Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
4.4. Top Investment Opportunities
4.5. Top Winning Strategies (2025)
4.6. Market Share Analysis (2024-2025)
4.7. Global Pricing Analysis And Trends 2025
4.8. Analyst Recommendation & Conclusion

Chapter 5. Global Vascular Imaging Market Size & Forecasts by Modality 2025-2035

5.1. Market Overview
5.2. Global Vascular Imaging Market Performance - Potential Analysis (2025)
5.3. CT
- 5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.3.2. Market size analysis, by region, 2025-2035
5.4. MRI
- 5.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.4.2. Market size analysis, by region, 2025-2035
5.5. Ultrasound
- 5.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.5.2. Market size analysis, by region, 2025-2035
5.6. Nuclear Medicine
- 5.6.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.6.2. Market size analysis, by region, 2025-2035

Chapter 6. Global Vascular Imaging Market Size & Forecasts by End-Use 2025-2035

6.1. Market Overview
6.2. Global Vascular Imaging Market Performance - Potential Analysis (2025)
6.3. Hospitals
- 6.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.3.2. Market size analysis, by region, 2025-2035
6.4. Imaging Centers
- 6.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.4.2. Market size analysis, by region, 2025-2035

Chapter 7. Global Vascular Imaging Market Size & Forecasts by Region 2025-2035

7.1. Vascular Imaging Market, Regional Market Snapshot
7.2. Top Leading & Emerging Countries
7.3. North America Vascular Imaging Market
- 7.3.1. U.S. Vascular Imaging Market
  - 7.3.1.1. Modality breakdown size & forecasts, 2025-2035
  - 7.3.1.2. End-Use breakdown size & forecasts, 2025-2035
- 7.3.2. Canada Vascular Imaging Market
  - 7.3.2.1. Modality breakdown size & forecasts, 2025-2035
  - 7.3.2.2. End-Use breakdown size & forecasts, 2025-2035
7.4. Europe Vascular Imaging Market
- 7.4.1. UK Vascular Imaging Market
  - 7.4.1.1. Modality breakdown size & forecasts, 2025-2035
  - 7.4.1.2. End-Use breakdown size & forecasts, 2025-2035
- 7.4.2. Germany Vascular Imaging Market
  - 7.4.2.1. Modality breakdown size & forecasts, 2025-2035
  - 7.4.2.2. End-Use breakdown size & forecasts, 2025-2035
- 7.4.3. France Vascular Imaging Market
  - 7.4.3.1. Modality breakdown size & forecasts, 2025-2035
  - 7.4.3.2. End-Use breakdown size & forecasts, 2025-2035
- 7.4.4. Spain Vascular Imaging Market
  - 7.4.4.1. Modality breakdown size & forecasts, 2025-2035
  - 7.4.4.2. End-Use breakdown size & forecasts, 2025-2035
- 7.4.5. Italy Vascular Imaging Market
  - 7.4.5.1. Modality breakdown size & forecasts, 2025-2035
  - 7.4.5.2. End-Use breakdown size & forecasts, 2025-2035
- 7.4.6. Rest of Europe Vascular Imaging Market
  - 7.4.6.1. Modality breakdown size & forecasts, 2025-2035
  - 7.4.6.2. End-Use breakdown size & forecasts, 2025-2035
7.5. Asia Pacific Vascular Imaging Market
- 7.5.1. China Vascular Imaging Market
  - 7.5.1.1. Modality breakdown size & forecasts, 2025-2035
  - 7.5.1.2. End-Use breakdown size & forecasts, 2025-2035
- 7.5.2. India Vascular Imaging Market
  - 7.5.2.1. Modality breakdown size & forecasts, 2025-2035
  - 7.5.2.2. End-Use breakdown size & forecasts, 2025-2035
- 7.5.3. Japan Vascular Imaging Market
  - 7.5.3.1. Modality breakdown size & forecasts, 2025-2035
  - 7.5.3.2. End-Use breakdown size & forecasts, 2025-2035
- 7.5.4. Australia Vascular Imaging Market
  - 7.5.4.1. Modality breakdown size & forecasts, 2025-2035
  - 7.5.4.2. End-Use breakdown size & forecasts, 2025-2035
- 7.5.5. South Korea Vascular Imaging Market
  - 7.5.5.1. Modality breakdown size & forecasts, 2025-2035
  - 7.5.5.2. End-Use breakdown size & forecasts, 2025-2035
- 7.5.6. Rest of APAC Vascular Imaging Market
  - 7.5.6.1. Modality breakdown size & forecasts, 2025-2035
  - 7.5.6.2. End-Use breakdown size & forecasts, 2025-2035
7.6. Latin America Vascular Imaging Market
- 7.6.1. Brazil Vascular Imaging Market
  - 7.6.1.1. Modality breakdown size & forecasts, 2025-2035
  - 7.6.1.2. End-Use breakdown size & forecasts, 2025-2035
- 7.6.2. Mexico Vascular Imaging Market
  - 7.6.2.1. Modality breakdown size & forecasts, 2025-2035
  - 7.6.2.2. End-Use breakdown size & forecasts, 2025-2035
7.7. Middle East and Africa Vascular Imaging Market
- 7.7.1. UAE Vascular Imaging Market
  - 7.7.1.1. Modality breakdown size & forecasts, 2025-2035
  - 7.7.1.2. End-Use breakdown size & forecasts, 2025-2035
- 7.7.2. Saudi Arabia (KSA) Vascular Imaging Market
  - 7.7.2.1. Modality breakdown size & forecasts, 2025-2035
  - 7.7.2.2. End-Use breakdown size & forecasts, 2025-2035
- 7.7.3. South Africa Vascular Imaging Market
  - 7.7.3.1. Modality breakdown size & forecasts, 2025-2035
  - 7.7.3.2. End-Use breakdown size & forecasts, 2025-2035

Chapter 8. Competitive Intelligence

8.1. Top Market Strategies
8.2. GE Healthcare
- 8.2.1. Company Overview
- 8.2.2. Key Executives
- 8.2.3. Company Snapshot
- 8.2.4. Financial Performance (Subject to Data Availability)
- 8.2.5. Product/Services Port
- 8.2.6. Recent Development
- 8.2.7. Market Strategies
- 8.2.8. SWOT Analysis
8.3. Siemens Healthineers
8.4. Philips Healthcare
8.5. Canon Medical Systems Corporation
8.6. Fujifilm Holdings Corporation
8.7. Hitachi Medical Corporation
8.8. Medtronic Plc
8.9. Baxter International Inc.
8.10. Boston Scientific Corporation
8.11. Bracco Imaging S.p.A
8.12. Canon U.S.A., Inc.
8.13. Shimadzu Corporation
8.14. Terumo Corporation
8.15. Stryker Corporation